Eileen McDermott quoted from our recent report on ‘Will the USMCA’s Requirements on Regulatory Data Protection increase spending on Medicines’ in an article at IPWatchdog.
Philip Stevens represented Geneva Network at the 2019 Summit of the GTIPA in Mexico City, joining representatives from 25 think tanks from around the world. On the agenda: Smart cities and society The impact on innovation and intellectual property on the USMCA and the EU-Mexico Modernised
Geneva Network and IDEAS joint roundtable on IP reform in Malaysia was profiled in Free Malaysia Today. Kyungjin Song, chairman of the International Cooperation, Innovative Economy Forum of South Korea, told the meeting that the IP industry had spurred her country’s economic growth. She said
Geneva Network research is quoted in this IPWatchdog article examining whether the IP provisions in the USMCA will raise medicine prices.
Following growing concern about the sustainability of healthcare systems, in the summer of 2016 EU Health Ministers invited the European Commission (EC) to undertake a review of the Intellectual Property (IP) incentives that underpin biomedical innovation. This document is a joint statement by a coalition
Asian thought leaders meet in Beijing to talk innovation, trade and health policy Many Asian countries are increasingly looking to the knowledge economy to complete the transition from middle-income to high income status. What are the policies that drive innovation and how are Asian countries
Alors que les populations sud africaines ont un besoin cruel de médicaments, les nouveaux médicaments ont un mal fou à pénétrer le marché du pays. Pourquoi ? Dans leur article, Urbach et Stevens, dénoncent la lourdeur de la réglementation sud africaine qui entrave lourdement la
Editor’s Note: This article first appeared in The MalayMail Online on 25th October 2016 Think tanks: Dengue Vaccine can save half of Malaysia’s RM735m dengue cost PETALING JAYA, Oct 25 ― Two think tanks argue that Malaysia can half the estimated US$175.7 million (RM735.3 million) economic
The UN High Level Report on Access to medicines threatens the nascent boom in biopharmaceutical R&D in middle-income such as India and China, according to Geneva Network, a UK-based research organisation working on international trade, health and intellectual property issues. Since China and India upgraded